Next Article in Journal
Self-Organization of Enzyme-Catalyzed Reactions Studied by the Maximum Entropy Production Principle
Next Article in Special Issue
Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression
Previous Article in Journal
CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us?

by
Igor Petrone
1,2,†,
Everton Cruz dos Santos
1,2,†,
Renata Binato
1,2 and
Eliana Abdelhay
1,2,*
1
Stem Cell Laboratory, Center for Bone Marrow Transplants, Brazilian National Cancer Institute—INCA, Rio de Janeiro 20230-240, Brazil
2
Stricto Sensu Graduate Program in Oncology, Brazilian National Cancer Institute—INCA, Rio de Janeiro 20230-240, Brazil
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(10), 8733; https://doi.org/10.3390/ijms24108733
Submission received: 4 April 2023 / Revised: 7 May 2023 / Accepted: 11 May 2023 / Published: 13 May 2023
(This article belongs to the Special Issue Epigenetic Modifiers (miRNA, lncRNA and Methylation) in Cancers)

Abstract

Some transcripts that are not translated into proteins can be encoded by the mammalian genome. Long noncoding RNAs (lncRNAs) are noncoding RNAs that can function as decoys, scaffolds, and enhancer RNAs and can regulate other molecules, including microRNAs. Therefore, it is essential that we obtain a better understanding of the regulatory mechanisms of lncRNAs. In cancer, lncRNAs function through several mechanisms, including important biological pathways, and the abnormal expression of lncRNAs contributes to breast cancer (BC) initiation and progression. BC is the most common type of cancer among women worldwide and has a high mortality rate. Genetic and epigenetic alterations that can be regulated by lncRNAs may be related to early events of BC progression. Ductal carcinoma in situ (DCIS) is a noninvasive BC that is considered an important preinvasive BC early event because it can progress to invasive BC. Therefore, the identification of predictive biomarkers of DCIS-invasive BC progression has become increasingly important in an attempt to optimize the treatment and quality of life of patients. In this context, this review will address the current knowledge about the role of lncRNAs in DCIS and their potential contribution to the progression of DCIS to invasive BC.
Keywords: epigenetic; long noncoding RNAs; DCIS progression; breast cancer epigenetic; long noncoding RNAs; DCIS progression; breast cancer

Share and Cite

MDPI and ACS Style

Petrone, I.; Santos, E.C.d.; Binato, R.; Abdelhay, E. Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us? Int. J. Mol. Sci. 2023, 24, 8733. https://doi.org/10.3390/ijms24108733

AMA Style

Petrone I, Santos ECd, Binato R, Abdelhay E. Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us? International Journal of Molecular Sciences. 2023; 24(10):8733. https://doi.org/10.3390/ijms24108733

Chicago/Turabian Style

Petrone, Igor, Everton Cruz dos Santos, Renata Binato, and Eliana Abdelhay. 2023. "Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us?" International Journal of Molecular Sciences 24, no. 10: 8733. https://doi.org/10.3390/ijms24108733

APA Style

Petrone, I., Santos, E. C. d., Binato, R., & Abdelhay, E. (2023). Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us? International Journal of Molecular Sciences, 24(10), 8733. https://doi.org/10.3390/ijms24108733

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop